机译:p53靶标Wig-1通过富含AU的元件调节p53 mRNA的稳定性
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
Institute of Cellular and Molecular Medicine, Panum Institute, University of Copenhagen, DK-2100 Copenhagen N, Denmark;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden Karolinska Institute, MTC, SE-171 77 Stockholm, Sweden;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
lnstitute of Cellular and Molecular Medicine, Panum Institute, University of Copenhagen, DK-2100 Copenhagen N, Denmark;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
lnstitute of Cellular and Molecular Medicine, Panum Institute, University of Copenhagen, DK-2100 Copenhagen N, Denmark;
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, SE-171 76 Stockholm, Sweden;
机译:p53靶标Wig-1:mRNA稳定性和干细胞命运的调节剂?
机译:Wig-1通过p53靶标FAS和14-3-3 |σ|调节细胞周期停滞和细胞死亡。
机译:Wig-1通过p53靶标FAS和14-3-3σ调节细胞周期停滞和细胞死亡
机译:microRNA-4732-5P WRAP53 mRNA的结合亲和力
机译:p53 N末端磷酸化和C末端多个翻译后修饰在调节p53对DNA损伤的反应中的功能分析。
机译:p53靶标Wig-1通过富含AU的元件调节p53 mRNA的稳定性
机译:p53靶标Wig-1通过富含AU的元件调节p53 mRNA的稳定性